“…However, side effects such as skin reactions may necessitate alternative therapy [6,24,36]. In addition, as many as 50% of isolates demonstrate TMP-SMX resistance, emphasizing the need for antibiotic susceptibility testing of clinical isolates [13,37,38]. N. farcinica is susceptible to TMP-SMX, minocycline, linezolid, moxifloxacin, and amikacin and demonstrates variable susceptible to imipenem-cilastatin and ciprofloxacin [20,[39][40][41][42][43].…”